Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma

PURPOSE: To identify and characterize gefitinib resistance-related (GefR-related) lncRNAs and construct a prediction model for lung adenocarcinoma (LUAD). METHODS: Differential expression analysis between PC9 and gefitinib-resistant PC9 (PC9GR) cell samples was performed to screen GefR-related lncRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Taoli, Wu, Zhulin, Li, Shiguang, Chen, Zhong, Chen, Yiqi, Yang, Zhenjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477152/
https://www.ncbi.nlm.nih.gov/pubmed/36118184
http://dx.doi.org/10.2147/IJGM.S369718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477152/
https://www.ncbi.nlm.nih.gov/pubmed/36118184
http://dx.doi.org/10.2147/IJGM.S369718

Ejemplares similares